# Enterprise Therapeutics funding: rounds and investors > Enterprise Therapeutics has raised $80M across 4 rounds since 2015. Investors include Versant Ventures, Novartis and Epidarex Capital. Source: https://millionrounds.com/company/enterprise-therapeutics (Millionrounds; every figure on the page links to its filing or article) United Kingdom · [Series B startup](https://millionrounds.com/companies) # Who invested in *Enterprise Therapeutics* 4 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$80M** raised across 4 rounds since 2015, from 4 sources **$2.5M** Series A **$3.7M** Series A **$41M** Series B **$33M** Series B - **Latest round:** Series B, $33M Jan 2024 - **Biggest round:** $41M Series B · Apr 2018 - **Investors:** 6 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2015 2017 2019 2021 2023 **$2.5M** Series A **$3.7M** Series A **$41M** Series B **$33M** Series B - **First round:** Series A, $2.5M - **Biggest round:** $41M - **Usual gap between rounds:** 2.9 years ## The rounds - **Jan 2024** Series B **$33M** *2 new* *2 returning* [Versant Ventures](https://millionrounds.com/fund/versant-ventures) [IP Group](https://millionrounds.com/fund/ip-group) [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) [Novartis](https://millionrounds.com/fund/novartis) Source recorded - **Apr 2018** Series B **$41M** *2 new* [Versant Ventures](https://millionrounds.com/fund/versant-ventures) [Novartis](https://millionrounds.com/fund/novartis) Reported by Fiercebiotech - **May 2015** Series A **$3.7M** *1 new* *1 returning* [Imperial Innovations Investment Management](https://millionrounds.com/fund/imperial-innovations-investment-management) [Epidarex Capital](https://millionrounds.com/fund/epidarex-capital) From a historical funding record - **Feb 2015** Series A **$2.5M** *1 new* [Epidarex Capital](https://millionrounds.com/fund/epidarex-capital) From a historical funding record ## Founders and team From Enterprise Therapeutics's own website: 11 on the team. - **Dr John Ford** Chief Executive Officer - **Dr Phil Boyd** Chief Financial Officer - **Dr Renu Gupta** Chief Medical Officer - **Prof Martin Gosling** Chief Scientific Officer - **Annabella Amatulli** Head of Regulatory - **Dr Eddie French** Head of CMC - **Dr Henry Danahay** Head of Biology - **Dr Sherry Armstrong-Wilkinson** Head of Quality and Clinical - **Dr Stephen Collingwood** Head of Chemistry - **Joanne Wagstaff** Head of Finance - **Kathy Woodward** Clinical Project Manager ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2015 **Series A** 2015 **Series B** 2018 **Series B** 2024 [Versant Ventures](https://millionrounds.com/fund/versant-ventures) [Novartis](https://millionrounds.com/fund/novartis) [Epidarex Capital](https://millionrounds.com/fund/epidarex-capital) [IP Group](https://millionrounds.com/fund/ip-group) [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) [Imperial Innovations Investment Management](https://millionrounds.com/fund/imperial-innovations-investment-management) ## Everyone who backed them [Versant Ventures](https://millionrounds.com/fund/versant-ventures) VC firm **2** rounds [Novartis](https://millionrounds.com/fund/novartis) VC firm **2** rounds [Epidarex Capital](https://millionrounds.com/fund/epidarex-capital) VC firm **2** rounds [IP Group](https://millionrounds.com/fund/ip-group) VC firm **1** round [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) Private equity **1** round [Imperial Innovations Investment Management](https://millionrounds.com/fund/imperial-innovations-investment-management) Investment firm **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=enterprise-therapeutics). ## Also claim to have backed them This firm lists Enterprise Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [Touchstone Innovations](https://millionrounds.com/fund/touchstone-innovations) VC firm Per its own site ## Quick answers about Enterprise Therapeutics ### Who invested in Enterprise Therapeutics? Enterprise Therapeutics's investors include Versant Ventures, Novartis, Epidarex Capital, IP Group and Forbion Capital Partners, and 1 more on record. ### How much has Enterprise Therapeutics raised? Enterprise Therapeutics has raised $80M across 4 rounds since 2015. ### When did Enterprise Therapeutics last raise? Enterprise Therapeutics's most recent round was a Series B of $33M in Jan 2024. ### What was Enterprise Therapeutics's biggest round? Enterprise Therapeutics's largest round on record is $41M (Series B), in Apr 2018. ### Who backed Enterprise Therapeutics first? Enterprise Therapeutics's first round on record, in Feb 2015, was backed by Epidarex Capital. ### What stage is Enterprise Therapeutics at? Enterprise Therapeutics's latest named round is a Series B, in Jan 2024. ### Where is Enterprise Therapeutics based? Enterprise Therapeutics is based in the United Kingdom. ## Companies like Enterprise Therapeutics In the same sector, and raised in the last eighteen months. [**Coherence Neuro** $55M · Oct 2026](https://millionrounds.com/company/coherence-neuro)[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**XRlabs** $8.4M · Oct 2026](https://millionrounds.com/company/xrlabs)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**MintNeuro** $26M · Oct 2026](https://millionrounds.com/company/mintneuro) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app